End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.38 CNY | -0.56% |
|
-0.83% | +12.48% |
08:39am | Sihuan Pharma Subsidiary Licenses Fadanafil Drug to Livzon Pharmaceutical Unit | MT |
06-06 | Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.48% | 4.41B | |
+50.37% | 781B | |
-7.46% | 350B | |
+18.26% | 330B | |
+7.55% | 293B | |
+16.77% | 248B | |
+0.53% | 221B | |
+11.06% | 217B | |
+3.29% | 162B | |
-4.38% | 157B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Livzon Pharmaceutical Group Inc. Announces Retirement of Xu Yanjun as an Independent Non-Executive Director